SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                             _____________________

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934



Date of Report (Date of earliest event reported)     April 17, 2007
                                                  ----------------------


                                ICU MEDICAL, INC.
                                -----------------
             (Exact name of registrant as specified in its charter)


            DELAWARE                      0-19974                33-0022692
            --------                      -------                ----------
(State or other jurisdiction of   (Commission File Number)    (I.R.S. Employer
         incorporation)                                      Identification No.)


951 Calle Amanecer, San Clemente, California                        92673
--------------------------------------------                        -----
  (Address of principal executive offices)                       (Zip Code)

                                 (949) 366-2183
                                 --------------
               Registrant's telephone number, including area code

                                       N/A
                                       ---
          (Former name or former address, if changed since last report)

         Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|      Written communications pursuant to Rule 425 under the Securities Act
         (17 CFR 230.425)

|_|      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
         CFR 240.14a-12)

|_|      Pre-commencement communications pursuant to Rule 14d-2(b) under the
         Exchange Act (17 CFR 240.14d-2(b))

|_|      Pre-commencement communications pursuant to Rule 13e-4(c) under the
         Exchange Act (17 CFR 240.13e-4(c))




                    INFORMATION TO BE INCLUDED IN THE REPORT



Item 8.01         Other Events
                  ------------

                  See attached press release.

Item 9.01         Financial Statements and Exhibits
                  ---------------------------------

        (c)       Exhibits

         99.1     Press release, dated April 17, 2007 announcing ICU Medical,
                  Inc.'s first quarter 2007 earnings release conference call.


                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  April 17, 2007

                                                 ICU MEDICAL, INC.


                                                 /s/ Francis J. O'Brien
                                                 ----------------------
                                                 Francis J. O'Brien
                                                 Secretary, Treasurer and
                                                 Chief Financial Officer